Matthias Klugmann, Ph.D.
Affiliations: | Translational Neuroscience Facility | The University of New South Wales, Australia |
Area:
gene therapy, glia, addiction, cannabinoids, brain metabolismWebsite:
http://medicalsciences.med.unsw.edu.au/people/associate-professor-matthias-klugmannGoogle:
"Matthias Klugmann"Mean distance: 14.8 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Klaus Armin Nave | grad student | MPI for Experimental Medicine | |
| Matthew During | post-doc | Univ Auckland |
Children
Sign in to add trainee| Andrew Paul Tosolini | grad student | 2011-2015 | University of New South Wales |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fröhlich D, Suchowerska AK, Voss C, et al. (2018) Expression Pattern of the Aspartyl-tRNA Synthetase DARS in the Human Brain. Frontiers in Molecular Neuroscience. 11: 81 |
| Datko MC, Hu JH, Williams M, et al. (2017) Behavioral and Neurochemical Phenotyping of Mice Incapable of Homer1a Induction. Frontiers in Behavioral Neuroscience. 11: 208 |
| von Jonquieres G, Spencer ZHT, Rowlands BD, et al. (2017) Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy. Acta Neuropathologica |
| Bi M, Gladbach A, van Eersel J, et al. (2017) Tau exacerbates excitotoxic brain damage in an animal model of stroke. Nature Communications. 8: 473 |
| Bassil F, Guerin PA, Dutheil N, et al. (2017) Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society |
| Georgiou E, Sidiropoulou K, Richter J, et al. (2017) Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model. Brain : a Journal of Neurology |
| Fröhlich D, Suchowerska AK, Spencer ZH, et al. (2016) In vivocharacterization of the aspartyl-tRNA synthetase DARS: Homing in on the leukodystrophy HBSL. Neurobiology of Disease |
| von Jonquieres G, Fröhlich D, Klugmann CB, et al. (2016) Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes. Frontiers in Molecular Neuroscience. 9: 13 |
| Guggenhuber S, Alpar A, Chen R, et al. (2015) Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus. Brain Structure & Function |
| Harasta AE, Power JM, von Jonquieres G, et al. (2015) Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1969-78 |